Voyager Therapeutics, Inc.
Public company- Headquarters
- LEXINGTON, Massachusetts
- Industry
- Biotechnology
- Ticker
- VYGR
- CIK
- 0001640266
WARN notices since 2024
0
None on record
Workers affected since 2024
0
Across 0 notices
Executive changes, last 12 months
1
1 appointment, 0 departures
Last event
Oct 21, 2026
Executive appointmentpresident appointed: Robin Swartz
Workers affected over time
Cumulative workers in WARN notices since 2024
Not enough notices to chart yet.
Leadership
| Role and person | Since | Change |
|---|---|---|
| presidentRobin Swartz | Oct 21, 2026 | Appointed |
Related companies
Same industry and state, with recent events.
- Eloxx Pharmaceuticals, Inc.
director appointed: Geno J. Germano
- TScan Therapeutics, Inc.
Director departs: Garry Nicholson
- Moderna, Inc.
COO appointed: Juan Andres
- REPLIGEN CORP
Board of Directors departs: Karen A. Dawes
- Executive appointment
president appointed: Robin Swartz
Robin Swartz was named president of Voyager Therapeutics, Inc., effective October 20, 2026. The company reported the change in an 8-K that cites Item 5.02.
Source: SEC 8-K, filed Oct 21, 2026Role: president
Only one public record so far. We add events as soon as a new filing lands; watch Voyager Therapeutics, Inc. to get them in your digest.
Last verified Nov 8, 2026